V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230001471 | 230000685 | 1.61 | 62.6 | Palliative (P) | 2016-12-08 | 2017-01-02 | Capecitabine | N | N | 230023028 | CAPECITABINE |
| 230001472 | 230000686 | 1.7 | 74.3 | Adjuvant (A) | null | 2017-11-09 | Capecitabine + Oxaliplatin 21day | N | N | 230023589 | OXALIPLATIN + MDG |
| 230001473 | 230000688 | 1.67 | null | Palliative (P) | 2018-02-20 | 2018-03-10 | Paclitaxel 7 day | N | null | 230024143 | IRINOTECAN |
| 230001474 | 230001314 | 1.78 | 85.2 | Palliative (P) | null | 2014-10-15 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | 230024456 | CAPECITABINE + OXALIPLATIN |
| 230001475 | 230000696 | 1.71 | 69.5 | Disease modification (D) | 2017-08-24 | 2017-09-05 | Irinotecan | 02 | N | 230024684 | IRINOTECAN + MDG |
| 230001476 | 230000699 | 1.75 | 82.8 | Adjuvant (A) | 2017-04-26 | 2017-05-14 | Cetuximab + Oxaliplatin + MdG Load | N | N | 230024788 | CAPECITABINE + OXALIPLATIN |
| 230001477 | 230000702 | 1.8 | 72.5 | Neo-adjuvant (N) | 2017-09-10 | 2017-09-23 | Capecitabine + Oxaliplatin 21day | 02 | N | 230025117 | SORAFENIB |
| 230001478 | 230000702 | 1.74 | 127.2 | Palliative (P) | 2017-10-12 | 2017-10-22 | Pazopanib | N | N | 230025117 | CETUXIMAB + IRINOTECAN + MDG |
| 230001479 | 230000703 | null | 72 | Palliative (P) | 2014-06-06 | 2014-08-13 | Cyclophosphamide + Fludarabine IV | N | null | 230025421 | FLUOROURACIL |
| 230001480 | 230000706 | 1.64 | null | Palliative (P) | 2019-04-27 | 2019-04-27 | AFLIBERCEPT + FU + IRINOTECAN | N | N | 230025748 | OXALIPLATIN + MDG |
| 230001481 | 230000709 | 1.65 | null | Palliative (P) | 2016-12-09 | 2016-12-09 | Trial Unspecified | N | N | 230025830 | CAPECITABINE + OXALIPLATIN |
| 230001482 | 230000711 | 1.77 | 69 | Palliative (P) | 2016-10-27 | 2016-11-10 | Capecitabine + Oxaliplatin 21day | null | N | 230026156 | IRINOTECAN + MDG |
| 230001483 | 230000713 | 1.59 | null | Palliative (P) | 2017-05-20 | 2017-05-20 | IVE | 02 | Y | 230026262 | PANITUMUMAB |
| 230001485 | 230000718 | 1.65 | 84 | Palliative (P) | 2013-03-18 | 2013-03-26 | Paclitaxel 7 day | Y | N | 230026784 | CAPECITABINE |
| 230001486 | 230000720 | 1.52 | 70.3 | Disease modification (D) | 2015-07-29 | 2015-08-30 | FEC 100 | N | N | 230026784 | CAPECITABINE |
| 230001487 | 230000724 | 1.57 | 72.1 | Adjuvant (A) | 2016-03-24 | 2016-03-24 | MPT | N | N | 230028556 | CAPECITABINE + RT |
| 230001488 | 230000726 | 1.78 | 61.7 | Neo-adjuvant (N) | 2015-09-25 | 2015-10-03 | Oxaliplatin + Modified de Gramont | 2 | N | 230000028 | OXALIPLATIN + RALTITREXED |
| 230001489 | 230000728 | 1.6 | 57.6 | Palliative (P) | 2016-12-27 | 2016-12-30 | Capecitabine | 2 | N | 230000042 | CAPECITABINE + OXALIPLATIN |
| 230001490 | 230000730 | 1.81 | 85.9 | Curative (C) | 2015-04-11 | 2015-04-12 | Capecitabine | 2 | N | 230000436 | OXALIPLATIN + MDG |
| 230001491 | 230000732 | 1.78 | null | Palliative (P) | 2015-10-15 | 2015-10-15 | Capecitabine | N | N | 230000436 | CAPECITABINE + OXALIPLATIN |
| 230001492 | 230001334 | 1.64 | null | Adjuvant (A) | 2015-06-15 | 2015-10-25 | Docetaxel | N | N | 230000550 | OXALIPLATIN + MDG |
| 230001493 | 230000735 | 1.76 | 69 | Adjuvant (A) | 2016-11-13 | 2016-11-27 | FLUOROURACIL + IRINOTECAN | N | N | 230000617 | FLUOROURACIL |
| 230001494 | 230000738 | 1.68 | 78.9 | Palliative (P) | 2017-02-20 | 2017-03-21 | Irinotecan + Modified De Gramont | N | N | 230000766 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 230001495 | 230000738 | null | 62.2 | Not known (9) | 2019-04-22 | 2019-04-22 | Capecitabine | null | N | 230000766 | CETUXIMAB |
| 230001496 | 230000742 | 1.57 | 58.4 | Curative (C) | 2016-02-17 | 2016-02-19 | Capecitabine | 02 | N | 230000889 | IPILIMUMAB |
| 230001497 | 230000744 | 1.64 | null | Palliative (P) | 2014-04-04 | 2014-04-11 | Paclitaxel 7 day | 99 | N | 230000898 | CAPECITABINE + OXALIPLATIN |
| 230001498 | 230000748 | 1.63 | 93.2 | Palliative (P) | 2018-11-06 | 2018-11-08 | Capecitabine | N | N | 230000976 | OXALIPLATIN + MDG |
| 230001499 | 230000750 | 1.77 | 83.4 | Adjuvant (A) | 2016-05-07 | 2016-05-20 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 02 | N | 230000981 | CETUXIMAB |
| 230001500 | 230000754 | 1.78 | 84 | Palliative (P) | 2017-05-23 | 2017-08-17 | Capecitabine + Oxaliplatin 21day | N | N | 230001034 | CAPECITABINE + OXALIPLATIN |
| 230001501 | 230000757 | 1.58 | 59.4 | Palliative (P) | 2019-02-22 | 2019-02-22 | Capecitabine + Oxaliplatin 21day | 2 | N | 230001261 | CAPECITABINE + OXALIPLATIN |
| 230001502 | 230000759 | 1.73 | 61.3 | Palliative (P) | 2015-12-13 | 2016-01-10 | Cisplatin + Doxorubicin | N | N | 230001387 | OXALIPLATIN + MDG |
| 230001503 | 230000761 | 1.71 | null | Palliative (P) | 2016-05-20 | 2016-06-04 | Sorafenib | N | N | 230001490 | CETUXIMAB + IRINOTECAN + MDG |
| 230001504 | 230000764 | 1.72 | 102 | Palliative (P) | 2016-07-10 | 2016-07-11 | Rituximab (Maintenance) | 2 | N | 230001512 | OXALIPLATIN + MDG |
| 230001505 | 230000767 | 1.78 | 113 | Palliative (P) | 2015-10-09 | 2015-10-10 | Irinotecan + Modified De Gramont | N | N | 230001578 | CAPECITABINE + OXALIPLATIN |
| 230001506 | 230000769 | null | 131 | Not known (9) | 2016-06-13 | 2016-06-14 | Capecitabine + Oxaliplatin 21day | N | N | 230001605 | CAPECITABINE |
| 230001507 | 230000771 | 1.67 | 81.6 | null | null | 2015-10-29 | Cetuximab + Oxaliplatin + MdG Load | 02 | N | 230001616 | OXALIPLATIN + MDG |
| 230001508 | 230000775 | 1.7 | 87 | Palliative (P) | 2014-07-12 | 2017-10-06 | Nintedanib | N | Y | 230001757 | IRINOTECAN + MDG |
| 230001509 | 230001342 | 1.57 | 84.7 | Palliative (P) | 2018-03-12 | 2018-03-18 | Cetuximab + FOLFIRI cycle 2 onwards | N | Y | 230001759 | CAPECITABINE + OXALIPLATIN |
| 230001510 | 230000780 | 1.51 | 46.7 | Palliative (P) | 2015-12-25 | 2016-01-07 | Docetaxel | 02 | N | 230002091 | CAPECITABINE + OXALIPLATIN |
| 230001511 | 230000781 | 0 | 60 | Curative (C) | 2015-11-28 | 2015-11-30 | MPT | N | Y | 230002108 | CAPECITABINE + OXALIPLATIN |
| 230001512 | 230001346 | null | 74.8 | Curative (C) | 2014-02-21 | 2014-02-21 | Cetuximab + FOLFIRI cycle 2 onwards | N | null | 230002226 | CAPECITABINE + OXALIPLATIN |
| 230001513 | 230001347 | 1.72 | 76.5 | Palliative (P) | 2015-11-21 | 2016-01-29 | IGEV R | N | N | 230002268 | MPT |
| 230001514 | 230000785 | null | 63 | Palliative (P) | 2009-07-11 | 2013-04-28 | CAPECITABINE + TEMOZOLOMIDE | 02 | N | 230002469 | AFLIBERCEPT + FU + IRINOTECAN |
| 230001515 | 230000789 | 1.85 | 92.9 | Curative (C) | 2015-11-06 | 2015-11-13 | CETUXIMAB | N | N | 230002610 | OXALIPLATIN + MDG |
| 230001516 | 230000791 | 1.9 | 83.4 | Adjuvant (A) | 2019-04-23 | 2019-05-08 | IRINOTECAN + MDG | N | N | 230002628 | OXALIPLATIN + MDG |
| 230001517 | 230000796 | 1.73 | null | Palliative (P) | 2016-12-22 | 2017-01-04 | Cisplatin + Vinorelbine (PO) | N | N | 230002716 | OXALIPLATIN + MDG |
| 230001518 | 230000797 | 1.71 | 46.7 | Adjuvant (A) | 2016-12-11 | 2016-12-17 | LENVATINIB | 02 | N | 230002716 | PACLITAXEL |
| 230001519 | 230001350 | 1.57 | 59.6 | Palliative (P) | 2019-04-28 | 2019-04-29 | FLUOROURACIL + IRINOTECAN | N | N | 230002744 | TRIFLURIDINE + TIPIRACIL |
| 230001520 | 230000800 | 1.53 | null | Adjuvant (A) | 2017-05-30 | 2018-06-29 | Rituximab | N | N | 230002819 | OXALIPLATIN + MDG |
| 230001521 | 230001352 | 1.82 | 92.1 | Adjuvant (A) | 2015-06-02 | 2015-06-14 | CAPECITABINE + OXALIPLATIN | N | N | 230003102 | CAPECITABINE + OXALIPLATIN |